Pernille Storm is a leading expert in global pricing and patient access, specializing in rare and neuroscience-driven innovation. With a background as Vice President for Global Pricing & Patient Access at Lundbeck, she has guided commercial strategy across the full lifecycle. from early R&D to launch and beyond, and supported more than 200 partnering evaluations. Today, as Founder of Access Elevate, she helps emerging biotechs translate scientific promise into compelling value stories that attract investors, satisfy payers, and ultimately reach more patients faster.